ASGR1 and neoplasm: Later work demonstrated that the combination of surface markers, Annexin V, EpCAM, ASGR1 and CD133, could be used to identify tumour-associated EVs in circulation and distinguish between liver cancers (HCC and cholangiocarcinoma) and tumour-free cirrhosis [125].